Objectives
NSCLC
NON-SMALL CELL LUNG CANCER, NSCLC
This study aimed to build and validate a prediction model that can predict progression-free survival (PFS) in patients with advanced non-small cell lung cancer (NSCLC) after image-guided microwave ablation (MWA) plus chemotherapy.